Sorin May Divest Vascular, Renal Units As Part Of Three-Year Restructuring
This article was originally published in The Gray Sheet
Executive Summary
The Sorin Group is considering selling its vascular and renal businesses to free up more resources for its core cardiac rhythm management, cardiopulmonary and heart valve units, and to pay down debt